Showing results (91-100 of 219) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2004
Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical centerMichael S Simon, Wei Du, Lawrence Flaherty, et al.
Cancer Metastasis Reviews|January 9, 2024
Deciphering cellular plasticity in pancreatic cancer for effective treatmentsMd Hafiz Uddin, Dingqiang Zhang, Irfana Muqbil, et al.
American Journal of Cancer Research|June 6, 2015
Contribution of microRNAs in understanding the pancreatic tumor microenvironment involving cancer associated stellate and fibroblast cellsShadan Ali, Raagini Suresh, Sanjeev Banerjee, et al.
American Journal of Clinical Oncology|January 3, 2019
Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma With the Introduction of New Chemotherapeutic Drugs: 10-Year Experience of a Single NCI-designated Comprehensive Cancer CenterKevin J Zhang, Greg Dyson, Joshua L Gatz, et al.
Gastroenterology|October 24, 2012
Selective inhibitors of nuclear export block pancreatic cancer cell proliferation and reduce tumor growth in miceAsfar S Azmi, Amro Aboukameel, Bin Bao, et al.
JAMA Network Open|October 17, 2024
Morphomics, Survival, and Metabolites in Patients With Metastatic Pancreatic CancerValerie Gunchick, Edward Brown, Juan Liu, et al.
Asia-Pacific Journal of Clinical Oncology|June 23, 2010
CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapyNazik Hammad, Lance K Heilbrun, Philip A Philip, et al.
Pancreas|May 15, 2010
Impact of race, age, and socioeconomic status on participation in pancreatic cancer clinical trialsBassel F El-Rayes, Pallavi Jasti, Richard K Severson, et al.
Cancer Research|April 15, 2010
Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDFShadan Ali, Aamir Ahmad, Sanjeev Banerjee, et al.
Small Gtpases|June 23, 2017
Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferationRamzi M Mohammad, Yiwei Li, Irfana Muqbil, et al.
Pageof 22